BD Star Capital

No named principals are cited in English-language public records. This opacity is common among smaller Chinese private equity firms that do not market internationally. Allocators conducting due diligence would typically confirm key decision-makers through direct introductions or Chinese-language regulatory disclosures.

Given its Beijing base and sector focus on AI, enterprise software, mobility, and digital health, the firm's deal flow likely originates through networks tied to Zhongguancun and Haidian District — home to Tsinghua and Peking universities, as well as the research labs and incubators feeding China's state-guided venture ecosystem. Direct introductions to founding teams at China's technology parks are standard sourcing channels for Beijing-based investors.

There is no public evidence of cross-border investments. The firm's known sector targeting — enterprise software, AI, mobility, digital health — and its Beijing headquarters suggest a domestic China mandate typical of onshore RMB-denominated funds structured to align with state industrial policies.

This is not ascertainable from public English-language sources. Many Beijing-based venture firms operate parallel RMB and USD vehicles; Chinese regulatory filings would clarify structure and foreign LP eligibility. International allocators should confirm vehicle type, capital controls exposure, and regulatory compliance status directly with the firm.

Per Altss research, the firm invests across early-stage (seed and start-up) through growth and general venture rounds. This stage breadth suggests a flexible mandate, but specific check sizes and reserve strategies are not publicly disclosed.